What is the recommended dose of lorazepam (Ativan) for seizure management in pediatric patients with a history of febrile seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lorazepam Dosing for Pediatric Seizure Management

For acute seizure management in pediatric patients, including those with febrile seizures, administer lorazepam 0.05-0.1 mg/kg IV (maximum 4 mg) given slowly at 2 mg/min when seizures last longer than 5 minutes. 1

Acute Seizure Treatment Protocol

First-Line Benzodiazepine Therapy

  • Lorazepam is the preferred first-line treatment for prolonged seizures (>5 minutes) in children, administered at 0.05-0.1 mg/kg IV with a maximum single dose of 4 mg, given slowly at 2 mg/min. 1, 2
  • The American Academy of Pediatrics recommends benzodiazepines as first-line treatment for any seizure lasting more than 5 minutes, regardless of whether the child has a history of febrile seizures or known epilepsy. 1
  • When IV access is not available, rectal diazepam should be administered instead, as IM diazepam has erratic absorption and is not recommended. 3

Clinical Context for Febrile Seizures

  • Most febrile seizures are self-limited and resolve spontaneously within 1-2 minutes without requiring medication. 3
  • Lorazepam administration is reserved for seizures that continue beyond 5 minutes, as these meet criteria for requiring acute intervention. 1
  • The treatment algorithm remains identical whether the child has a history of febrile seizures or is experiencing their first seizure. 1

Important Distinctions: Acute vs. Prophylactic Management

What Lorazepam IS Used For

  • Acute termination of active seizures lasting >5 minutes 1, 2
  • Emergency seizure control in the hospital or prehospital setting 4
  • Lorazepam has demonstrated 100% success rate in terminating convulsive status epilepticus in pediatric patients when used appropriately. 5

What Lorazepam IS NOT Used For

  • Prophylactic prevention of febrile seizure recurrence - this is explicitly NOT recommended by the American Academy of Pediatrics. 1, 3
  • Long-term seizure prevention in children with simple febrile seizures 1
  • Routine anticonvulsant prophylaxis after a first afebrile seizure 2

Critical Management Principles

Why Prophylaxis Is Not Recommended

  • The American Academy of Pediatrics explicitly recommends against continuous or intermittent anticonvulsant prophylaxis for simple febrile seizures because potential toxicities clearly outweigh minimal risks. 1, 3
  • Simple febrile seizures cause no long-term adverse effects on IQ, academic performance, neurocognitive function, or structural brain damage. 1
  • The risk of developing epilepsy after simple febrile seizures is approximately 1% (identical to the general population). 1
  • Even children with multiple risk factors (age <12 months at first seizure, family history of epilepsy, multiple simple febrile seizures) have only 2.4% risk of developing epilepsy by age 25 years. 1

Recurrence Risk Does Not Justify Prophylaxis

  • Children younger than 12 months at first seizure have approximately 50% probability of recurrent febrile seizures, while those older than 12 months have approximately 30% probability. 1
  • Despite these recurrence rates, the harm-benefit analysis clearly favors no prophylactic treatment. 1
  • Antipyretics (acetaminophen, ibuprofen) do not prevent febrile seizures or reduce recurrence risk, though they may improve comfort. 1, 3

Common Pitfalls to Avoid

Inappropriate Prophylactic Prescribing

  • Never prescribe continuous phenobarbital or valproic acid for simple febrile seizures - these carry unacceptable risks including rare fatal hepatotoxicity (valproic acid), hyperactivity, irritability, lethargy, and cognitive impairment (phenobarbital causes mean IQ reduction of 7 points during treatment). 1
  • Do not prescribe intermittent diazepam prophylaxis during febrile illnesses for simple febrile seizures, as it does not improve long-term outcomes and causes lethargy, drowsiness, and ataxia. 1
  • Rescue medications (rectal diazepam or buccal midazolam) may be prescribed for patients with known epilepsy, but this is different from prophylactic prevention of febrile seizure recurrence. 1

Appropriate Supportive Care During Seizures

  • Position the patient on their side, remove harmful objects, and protect the head from injury. 1
  • Never restrain the patient or place anything in the mouth during active seizure activity. 1, 3
  • Provide gradual passive cooling for febrile seizures, avoiding rapid cooling measures that may induce shivering. 4

When to Administer Lorazepam

Clear Indications

  • Any seizure (febrile or afebrile) lasting longer than 5 minutes 1, 2
  • Convulsive status epilepticus 5
  • Multiple seizures without return to baseline 3

Administration Details

  • Dose: 0.05-0.1 mg/kg IV 1, 2
  • Maximum single dose: 4 mg 1
  • Rate: 2 mg/min 1
  • May require a second dose if seizure does not terminate with initial administration 5

Safety Profile

  • Lorazepam is as safe and efficacious as diazepam-phenytoin combination for pediatric convulsive status epilepticus. 5
  • Respiratory depression occurs in approximately 4-5% of patients, similar to other benzodiazepines. 5
  • No patients in controlled trials required mechanical ventilation when lorazepam was used appropriately. 5

References

Guideline

Pediatric Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Pediatric Afebrile Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Febrile and Absence Seizures: Clinical Presentation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Handle with care.

Emergency medical services, 2004

Research

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.